Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

The Effect of Feverfew Cultivated in Iran for the Prophylactic Treatment of Migraine: A Randomized Placebo-controlled Clinical Trial

Shahram Rafie 1 , Forough Namjoyan 2 , Alireza Hassanzadeh 1 , Fatemeh Yousefbeyk 3 , Shokouhsadat Hamedi 4 and Fereshteh Golfakhrabadi 2 , *
Authors Information
1 Department of Neurology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Pharmacognosy, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Department of Pharmacognosy, School of Pharmacy, Guilan University of Medical Sciences, Rasht, IR Iran
4 Department of Persian Pharmacy, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: February 01, 2016, 11 (1); e29275
  • Published Online: November 28, 2015
  • Article Type: Research Article
  • Received: April 22, 2015
  • Revised: August 21, 2015
  • Accepted: August 29, 2015
  • DOI: 10.17795/jjnpp-29275

To Cite: Rafie S, Namjoyan F, Hassanzadeh A, Yousefbeyk F, Hamedi S, et al. The Effect of Feverfew Cultivated in Iran for the Prophylactic Treatment of Migraine: A Randomized Placebo-controlled Clinical Trial, Jundishapur J Nat Pharm Prod. 2016 ; 11(1):e29275. doi: 10.17795/jjnpp-29275.

Copyright © 2015, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Fantasia HC. Migraine headache prophylaxis in adolescents. Nurs Womens Health. 2014; 18(5): 420-4[DOI][PubMed]
  • 2. Magis D, Schoenen J. Treatment of migraine: update on new therapies. Curr Opin Neurol. 2011; 24(3): 203-10[DOI][PubMed]
  • 3. Chayasirisobhon S. Efficacy of Pinus radiata bark extract and vitamin C combination product as a prophylactic therapy for recalcitrant migraine and long-term results. Acta Neurol Taiwan. 2013; 22(1): 13-21[PubMed]
  • 4. Prior MJ, Codispoti JR, Fu M. A randomized, placebo-controlled trial of acetaminophen for treatment of migraine headache. Headache. 2010; 50(5): 819-33[DOI][PubMed]
  • 5. D'Amico D, Solari A, Usai S, Santoro P, Bernardoni P, Frediani F, et al. Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study. Cephalalgia. 2006; 26(6): 691-6[DOI][PubMed]
  • 6. Lipton RB, Gobel H, Einhaupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology. 2004; 63(12): 2240-4[PubMed]
  • 7. Bradley PR. British Herbal Compendium A Handbook of Scientific Information on Widely Used Plant Drugs. 1992;
  • 8. Ernst E, Pittler MH. The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review. Public Health Nutr. 2000; 3(4A): 509-14[PubMed]
  • 9. Mabey DC, Tedder RS, Hughes AS, Corrah PT, Goodison SJ, O'Connor T, et al. Human retroviral infections in The Gambia: prevalence and clinical features. Br Med J (Clin Res Ed). 1988; 296(6615): 83-6[PubMed]
  • 10. Murphy JJ, Heptinstall S, Mitchell JR. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet. 1988; 2(8604): 189-92[PubMed]
  • 11. Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia. 2002; 22(7): 523-32[PubMed]
  • 12. Johnson ES, Kadam NP, Hylands DM, Hylands PJ. Efficacy of feverfew as prophylactic treatment of migraine. Br Med J (Clin Res Ed). 1985; 291(6495): 569-73[PubMed]
  • 13. Rose J. Feverfew in the Treatment of Migraine. Clin nutr insights. 1998; 6: 1-2
  • 14. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia. 1988; 8 Suppl 7: 1-96[PubMed]
  • 15. Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K, Liberman JN, et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology. 1999; 53(5): 988-94[PubMed]
  • 16. Pareek A, Suthar M, Rathore GS, Bansal V. Feverfew (Tanacetum parthenium L.): A systematic review. Pharmacogn Rev. 2011; 5(9): 103-10[DOI][PubMed]
  • 17. Awang DV. Fever few: A headache for the consumer. HerbalGram. 1993; 29: 34-5
  • 18. Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom. 2004; 18(19): 2273-81[DOI][PubMed]
  • 19. Bone K, Mills S. Principles and practice of phytotherapy: modern herbal medicine. 2013; : 570
  • 20. Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache. 2004; 44(9): 885-90[DOI][PubMed]
  • 21. Shrivastava R, Pechadre JC, John GW. Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study. Clin Drug Investig. 2006; 26(5): 287-96[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments